# Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38

> **NCT07342296** · NA · NOT_YET_RECRUITING · sponsor: **Danish Headache Center** · enrollment: 21 (estimated)

## Conditions studied

- Migraine With Aura
- Migraine Aura

## Interventions

- **DRUG:** Pituitary Adenylate Cyclase Activating Polypeptide-38 (PACAP-38)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07342296
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-30
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07342296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07342296, "Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07342296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*